R&D

Scientific Research for the Therapies of the Future

HealgenetiX clinical research programs are conducted to scientifically evaluate the safety and efficacy of new drugs and biotechnological treatment solutions. Our clinical studies are designed in accordance with international research standards and are carried out under the supervision of independent ethics committees.

The primary aim of our research is to provide patients with safer, more effective, and innovative treatment options.

Our Research Areas

Gene Therapies

Our gene therapy research aims to develop advanced biotechnological solutions for correcting genetic mutations. DNA- and RNA-based therapeutic approaches are creating new opportunities for the treatment of hereditary diseases.

Neurological Diseases

Our research projects focused on neurodegenerative diseases aim to develop molecular therapies that support the protection and regeneration of nerve cells.

Immune Systems

Studies on immunomodulatory biological therapies aim to provide next-generation solutions for autoimmune diseases and chronic inflammatory disorders.

Our Technology Platforms

The HealgenetiX R&D infrastructure is equipped with advanced technological systems required for modern biotechnology research.

Our research platforms include:

Gene editing technologies
Molecular biology and genetic analysis systems
Cell culture and biotechnology laboratories
AI-powered drug discovery platforms
Bioinformatics analysis infrastructure

Thanks to these technology platforms, the discovery and development of new molecules are carried out faster and more reliably.